Search International and National Patent Collections
Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO1992009278) SUBSTITUTED 5-ARYL IMIDAZOLES
Latest bibliographic data on file with the International Bureau

Pub. No.: WO/1992/009278 International Application No.: PCT/US1991/008426
Publication Date: 11.06.1992 International Filing Date: 12.11.1991
Chapter 2 Demand Filed: 10.06.1992
IPC:
C07D 233/54 (2006.01)
C CHEMISTRY; METALLURGY
07
ORGANIC CHEMISTRY
D
HETEROCYCLIC COMPOUNDS
233
Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
54
having two double bonds between ring members or between ring members and non-ring members
Applicants:
SMITHKLINE BEECHAM CORPORATION [US/US]; Corporate Patent - U.S. 709 Swedeland Road P.O. Box 1539 King of Prussia, PA 19406, US
Inventors:
KEENAN, Richard, McCulloch; US
MORGAN, Tina; US
Agent:
McCARTHY, Mary, E. ; SmithKline Beecham Corporation Corporate Patents - U.S. (UW2220) 709 Swedeland Road, P.O. Box 1538 King of Prussia, PA 19406-0939, US
Priority Data:
621,18830.11.1990US
Title (EN) SUBSTITUTED 5-ARYL IMIDAZOLES
(FR) IMIDAZOLES 5-ARYLE SUBSTITUES
Abstract:
(EN) Angiotensin II receptor antagonists having formula (1) which are useful in regulating hypertension and in the treatment of congestive heart failure, renal failure, and glaucoma, pharmaceutical compositions including these antagonists, and methods of using these compounds to produce angiontensin II receptor antagonism in mammals.
(FR) L'invention se rapporte à des antagonistes du récepteur de l'angiotensine II, qui sont représentés par la formule (1) et qui sont utiles pour lutter contre l'hypertension et pour traiter les défaillances cardiaques congestives, les défaillances rénales et le glaucome, ainsi qu'à des compositions pharmaceutiques contenant ces antagonistes et à des procédés d'utilisation de tels composés pour produire une action antagoniste contre le récepteur de l'angiotensine II chez les mammifères.
Designated States: AU, CA, JP, KR
European Patent Office (AT, BE, CH, DE, DK, ES, FR, GB, GR, IT, LU, NL, SE)
Publication Language: English (EN)
Filing Language: English (EN)
Also published as:
EP0559755JPH06503562AU1991090553